Lipocine (LPCN) Misses Q3 EPS by 67c

Lipocine (NASDAQ: LPCN) reported Q3 EPS of ($1.27), $0.67 worse than the analyst estimate of ($0.60).

For earnings history and earnings-related data on Lipocine (LPCN) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Arrive AI and DXC Technology partner to bring delivery tech to factories
• Can global equities keep rising? UBS sees these factors driving upside